Furthermore, studies using flow cytometry have shown that in EC cell lines RL95-2 and RL95-2/Oct-4, heightened levels of octamer-binding transcription factor 4 (Oct-4) resulted in a doubling of cancer stem cell markers CD133 and aldehyde dehydrogenase 1 (ALDH1). The gene discussed is POU5F1; the disease is cancer.